Stay updated with breaking news from Assembly Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their neutral rating on shares of Assembly Biosciences (NASDAQ:ASMB – Free Report) in a research note issued to investors on Monday, Benzinga reports. HC Wainwright also issued estimates for Assembly Biosciences’ Q1 2024 earnings at ($2.74) EPS, Q2 2024 earnings at ($2.96) EPS, Q3 2024 earnings at ($3.29) EPS, Q4 2024 earnings […]
In the world of investing, spotting stocks that are gaining momentum is a well-worn strategy for those seeking potential profits. These stocks, exhibiting remarkable movements, often sustain their...
Wall Street brokerages forecast that Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Rating) will report earnings per share of ($0.54) for the current quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Assembly Biosciences’ earnings. The lowest EPS estimate is ($0.57) and the highest is ($0.51). Assembly Biosciences reported earnings of ($0.55) per share […]
Gemini Therapeutics (NASDAQ:GMTX – Get Rating) and Assembly Biosciences (NASDAQ:ASMB – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Gemini Therapeutics and […]
Analysts expect Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Rating) to announce earnings per share of ($0.49) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Assembly Biosciences’ earnings. The highest EPS estimate is ($0.35) and the lowest is ($0.56). Assembly Biosciences posted earnings per share of ($0.69) in the same quarter […]